Product Name

  • Name

    Sulfosalicylic acid

  • EINECS 202-555-6
  • CAS No. 97-05-2
  • Density 1.771 g/cm3
  • Solubility 987g/L at 20℃
  • Melting Point 120 °C
  • Formula C7H6O6S
  • Boiling Point 328.86°C (rough estimate)
  • Molecular Weight 218.187
  • Flash Point
  • Transport Information UN 1760
  • Appearance White to off-white, hygroscopic, crystalline powder
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 97-05-2 (Sulfosalicylic acid)
  • Hazard Symbols
  • Synonyms Salicylicacid, 5-sulfo- (8CI);2-Hydroxy-5-sulfobenzoic acid;3-Carboxy-4-hydroxybenzenesulfonic acid;5-(Hydroxysulfonyl)salicylic acid;5-Sulfosalicylic acid;5-Sulphosalicylic acid;NSC 190565;NSC 4741;SSA;Salicylsulfonic acid;Sulfosalicylic acid;Sulphosalicylic acid;
  • PSA 120.28000
  • LogP 1.41790

Synthetic route

phenyl Salicylate
118-55-8

phenyl Salicylate

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Conditions
ConditionsYield
With sulfuric acid
salicylic acid
69-72-7

salicylic acid

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Conditions
ConditionsYield
With sulfuric acid
With sulfur trioxide
With sulfuric acid
With sulfuric acid Abpressen des entstandenen Krystallbreis und Eintragen in gesaettigte Kochsalzloesung;
With chlorosulfonic acid at 160℃; Zersetzung des Produktes mit Wasser;
2-oxo-2H-chromene-6-sulfonic acid
27279-86-3

2-oxo-2H-chromene-6-sulfonic acid

alkaline permanganate solution

alkaline permanganate solution

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

2-oxo-2H-chromene-3,6-disulfonic acid
69089-38-9

2-oxo-2H-chromene-3,6-disulfonic acid

alkaline permanganate solution

alkaline permanganate solution

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

4-methyl-2-oxo-2H-chromene-6-sulfonic acid

4-methyl-2-oxo-2H-chromene-6-sulfonic acid

permanganate

permanganate

barytesalkali

barytesalkali

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

4-methyl-2-oxo-2H-chromene-3,6-disulfonic acid

4-methyl-2-oxo-2H-chromene-3,6-disulfonic acid

permanganate

permanganate

barytesalkali

barytesalkali

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

phenyl Salicylate
118-55-8

phenyl Salicylate

sulfuric acid (excess)

sulfuric acid (excess)

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

chlorosulfonic acid
7790-94-5

chlorosulfonic acid

salicylic acid
69-72-7

salicylic acid

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Conditions
ConditionsYield
at 160℃;
sulfuric acid
7664-93-9

sulfuric acid

salicylic acid
69-72-7

salicylic acid

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

sulfur trioxide
7446-11-9

sulfur trioxide

salicylic acid
69-72-7

salicylic acid

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

coumarin-disulfonic acid-(3.6)

coumarin-disulfonic acid-(3.6)

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Conditions
ConditionsYield
With potassium hydroxide; permanganate(VII) ion
coumarin-sulfonic acid-(6)

coumarin-sulfonic acid-(6)

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Conditions
ConditionsYield
With potassium hydroxide; permanganate(VII) ion
monopotassium-salt of/the/ 6-bromo-3-sulfo-benzoic acid

monopotassium-salt of/the/ 6-bromo-3-sulfo-benzoic acid

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Conditions
ConditionsYield
With water; copper; potassium carbonate at 170℃;
monopotassium-salt of/the/ 6-chloro-3-sulfo-benzoic acid

monopotassium-salt of/the/ 6-chloro-3-sulfo-benzoic acid

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Conditions
ConditionsYield
With water; copper; potassium carbonate at 170℃;
5-sulpho-2-hydroxybenzaldehyde
25149-61-5

5-sulpho-2-hydroxybenzaldehyde

silver oxide

silver oxide

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

2-hydroxy-5-methoxysulfonylbenzoicacid methyl ester
83957-15-7

2-hydroxy-5-methoxysulfonylbenzoicacid methyl ester

alcoholic KOH-solution

alcoholic KOH-solution

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

hydrogenchloride
7647-01-0

hydrogenchloride

ethanol
64-17-5

ethanol

diboric acid-1,2-bis-(2-carboxy-4-sulfo-phenyl ester); disodium salt

diboric acid-1,2-bis-(2-carboxy-4-sulfo-phenyl ester); disodium salt

A

metaboric acid
13460-50-9

metaboric acid

B

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

3-bromo-2-hydroxy-5-sulfobenzoic acid
50390-26-6

3-bromo-2-hydroxy-5-sulfobenzoic acid

Conditions
ConditionsYield
With bromine In water100%
With water; bromine
5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

(S)-(+)-clopidogrel
113665-84-2

(S)-(+)-clopidogrel

methyl (+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate 5-sulfosalicylate
1010080-15-5

methyl (+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate 5-sulfosalicylate

Conditions
ConditionsYield
In methanol at 30℃; for 0.5h;100%
In dichloromethane at 20℃; for 0.5 - 1h; Product distribution / selectivity; Heating / reflux;100%
methanol
67-56-1

methanol

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

5-sulfosalicylic methyl ester
92333-05-6

5-sulfosalicylic methyl ester

Conditions
ConditionsYield
for 18h; Reflux;100%
p-aminobenzamidine
3858-83-1

p-aminobenzamidine

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

4-aminobenzamidinium bis(5-sulfosalicylate)monohydrate

4-aminobenzamidinium bis(5-sulfosalicylate)monohydrate

Conditions
ConditionsYield
With water In methanol95%
2-amino-3-benzyloxypyridine
24016-03-3

2-amino-3-benzyloxypyridine

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

C12H12N2O*C7H6O6S

C12H12N2O*C7H6O6S

Conditions
ConditionsYield
In ethanol for 3h; Reflux;95%
3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

2-Hydroxy-5-sulfo-benzoic acid; compound with 1,3,7-trimethyl-3,7-dihydro-purine-2,6-dione
60473-74-7

2-Hydroxy-5-sulfo-benzoic acid; compound with 1,3,7-trimethyl-3,7-dihydro-purine-2,6-dione

Conditions
ConditionsYield
In methanol; water at 20℃; for 0.5h;94.36%
copper diacetate
142-71-2

copper diacetate

1,5-diamino-3-azapentane
111-40-0

1,5-diamino-3-azapentane

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Cu(2+)*2(O3SC6H3OCOO)Cu(C4H13N3)(H2O)(1-)*6H2O = Cu[(O3SC6H3OCOO)Cu(C4H13N3)(H2O)]2*6H2O

Cu(2+)*2(O3SC6H3OCOO)Cu(C4H13N3)(H2O)(1-)*6H2O = Cu[(O3SC6H3OCOO)Cu(C4H13N3)(H2O)]2*6H2O

Conditions
ConditionsYield
In N,N-dimethyl-formamide Cu-salt/triamine/salicylic acid molar ratio 3:2:2; refluxing (2 h); recrystn. (water), drying (room temp., red. pressure); elem. anal.;94%
pentaphenylphosphorane
2588-88-7

pentaphenylphosphorane

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

tetraphenylphosphonium sulfosalicylate

tetraphenylphosphonium sulfosalicylate

Conditions
ConditionsYield
In benzene at 80℃; for 0.166667h;93%
5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

6-amino-5-nitro-2-picoline
21901-29-1

6-amino-5-nitro-2-picoline

C6H7N3O2*C7H6O6S

C6H7N3O2*C7H6O6S

Conditions
ConditionsYield
In ethanol for 3h; Reflux;93%
1,5-diamino-3-azapentane
111-40-0

1,5-diamino-3-azapentane

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Ni(2+)*2(O3SC6H3OCOO)Ni(C4H13N3)(H2O)(1-)*6H2O = Ni[(O3SC6H3OCOO)Ni(C4H13N3)(H2O)]2*6H2O

Ni(2+)*2(O3SC6H3OCOO)Ni(C4H13N3)(H2O)(1-)*6H2O = Ni[(O3SC6H3OCOO)Ni(C4H13N3)(H2O)]2*6H2O

Conditions
ConditionsYield
In N,N-dimethyl-formamide Ni-salt/triamine/salicylic acid molar ratio 3:2:2; refluxing (2.5 h); recrystn. (water), drying (room temp., red. pressure); elem. anal.;92%
copper diacetate
142-71-2

copper diacetate

1,5-diamino-3-azapentane
111-40-0

1,5-diamino-3-azapentane

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Cu(C4H13N3)(H2O)3(2+)*2(O3SC6H3OCOO)Cu(C4H13N3)(H2O)(1-)*5H2O = [Cu(C4H13N3)(H2O)3][(O3SC6H3OCOO)Cu(C4H13N3)(H2O)]2*5H2O

Cu(C4H13N3)(H2O)3(2+)*2(O3SC6H3OCOO)Cu(C4H13N3)(H2O)(1-)*5H2O = [Cu(C4H13N3)(H2O)3][(O3SC6H3OCOO)Cu(C4H13N3)(H2O)]2*5H2O

Conditions
ConditionsYield
In N,N-dimethyl-formamide Cu-salt/triamine/salicylic acid molar ratio 3:3:2; refluxing; recrystn. (water), drying (room temp., red. pressure); elem. anal.;92%
5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

aripiprazole
129722-12-9

aripiprazole

7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydro-2(1H)-quinolinone 5-sulfosalicylate
1246273-26-6

7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydro-2(1H)-quinolinone 5-sulfosalicylate

Conditions
ConditionsYield
In chloroform for 2h; Product distribution / selectivity; Reflux;91%
pentaphenylantimony
2170-05-0

pentaphenylantimony

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

tetraphenylstibonium sulfosalicylate
194939-13-4

tetraphenylstibonium sulfosalicylate

Conditions
ConditionsYield
In ethanol; toluene byproducts: C6H6; room temp., several min; evapn., recrystn. (ethanol-water, 5:1);90.6%
pentaphenylantimony
2170-05-0

pentaphenylantimony

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

5-(tetraphenylantimoniooxysulfonyl)salicylic acid
194939-13-4

5-(tetraphenylantimoniooxysulfonyl)salicylic acid

Conditions
ConditionsYield
In ethanol; toluene soln. of Sb-compd. in toluene addn. to ethanolic soln. of acid, standingat room temperature for few minutes; solvent removing, residue re-crystn. (ethanol-water);90.6%
copper diacetate
142-71-2

copper diacetate

1,5-diamino-3-azapentane
111-40-0

1,5-diamino-3-azapentane

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Cu(C4H13N3)2(2+)*2(O3SC6H3OCOO)Cu(C4H13N3)(H2O)(1-)*10H2O = [Cu(C4H13N3)2][(O3SC6H3OCOO)Cu(C4H13N3)(H2O)]2*10H2O

Cu(C4H13N3)2(2+)*2(O3SC6H3OCOO)Cu(C4H13N3)(H2O)(1-)*10H2O = [Cu(C4H13N3)2][(O3SC6H3OCOO)Cu(C4H13N3)(H2O)]2*10H2O

Conditions
ConditionsYield
In N,N-dimethyl-formamide Cu-salt/triamine/salicylic acid molar ratio 3:4:2; refluxing (2 h); recrystn. (water), drying (room temp., red. pressure); elem. anal.;90%
N,N'-dimethylpiperazine
106-58-1

N,N'-dimethylpiperazine

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

0.5C6H14N2*C7H6O6S

0.5C6H14N2*C7H6O6S

Conditions
ConditionsYield
In water90%
terbium

terbium

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

terbium(III)(5-sulfosalicylate)3

terbium(III)(5-sulfosalicylate)3

Conditions
ConditionsYield
In acetonitrile at 30℃; Inert atmosphere; Sealed tube; Electrochemical reaction; Sonication;90%
gadolinium

gadolinium

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

gadolinium(III)(5-sulfosalicylate)3

gadolinium(III)(5-sulfosalicylate)3

Conditions
ConditionsYield
In acetonitrile at 30℃; Inert atmosphere; Sealed tube; Electrochemical reaction; Sonication;90%
2-amino-3-hydroxypyridine
16867-03-1

2-amino-3-hydroxypyridine

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

C5H6N2O*C7H6O6S

C5H6N2O*C7H6O6S

Conditions
ConditionsYield
In ethanol for 3h; Reflux;90%
manganese(II) perchlorate hexahydrate

manganese(II) perchlorate hexahydrate

copper(II) 2,3-dioxo-5,6,14,15-dibenzo-1,4,8,12-tetraazacyclopentadeca-7,13-dien
60911-04-8

copper(II) 2,3-dioxo-5,6,14,15-dibenzo-1,4,8,12-tetraazacyclopentadeca-7,13-dien

water
7732-18-5

water

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Mn(III)Mn(II)2(5-sulfosalicylate(3-))2(Cu(II)(2,3-dioxo-5,6,14,15-dibenzo-1,4,8,12-tetraazacyclopentadeca-7,13-diene))2(OH)(H2O)3

Mn(III)Mn(II)2(5-sulfosalicylate(3-))2(Cu(II)(2,3-dioxo-5,6,14,15-dibenzo-1,4,8,12-tetraazacyclopentadeca-7,13-diene))2(OH)(H2O)3

Conditions
ConditionsYield
With NaOH; air In methanol; water High Pressure; under hydrothermal conditions; mixt. of Mn salt, 5-sulfosalicylic acid, Cu complex, H2O and MeOH stirred at room temp. for 40 min; pH adjusted to 7-8 (1M NaOH); heated at 160°C for 72 h; cooled to room temp. for 36 h; crystals isolated by filtration; washed with H2O; elem. anal.;89.5%
copper diacetate
142-71-2

copper diacetate

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Cu(2+)*2(O3SC6H3OCOO)Cu(H2O)4(1-)*8H2O = Cu[(O3SC6H3OCOO)Cu(H2O)4]2*8H2O

Cu(2+)*2(O3SC6H3OCOO)Cu(H2O)4(1-)*8H2O = Cu[(O3SC6H3OCOO)Cu(H2O)4]2*8H2O

Conditions
ConditionsYield
In N,N-dimethyl-formamide Cu-salt/salicylic acid molar ratio 3:2; refluxing (1 h); recrystn. (water), drying (room temp., red. pressure); elem. anal.;89%
1,5-diamino-3-azapentane
111-40-0

1,5-diamino-3-azapentane

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Ni(C4H13N3)(H2O)3(2+)*2(O3SC6H3OCOO)Ni(C4H13N3)(H2O)(1-)*5H2O = [Ni(C4H13N3)(H2O)3][(O3SC6H3OCOO)Ni(C4H13N3)(H2O)]2*5H2O

Ni(C4H13N3)(H2O)3(2+)*2(O3SC6H3OCOO)Ni(C4H13N3)(H2O)(1-)*5H2O = [Ni(C4H13N3)(H2O)3][(O3SC6H3OCOO)Ni(C4H13N3)(H2O)]2*5H2O

Conditions
ConditionsYield
In N,N-dimethyl-formamide Ni-salt/triamine/salicylic acid molar ratio 3:3:2; refluxing (2.5 h); recrystn. (water), drying (room temp., red. pressure); elem. anal.;88%
zinc(II) chloride tetrahydrate
29604-34-0

zinc(II) chloride tetrahydrate

water
7732-18-5

water

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Zn(2+)*2C7H5O6S(1-)*9.1H2O

Zn(2+)*2C7H5O6S(1-)*9.1H2O

Conditions
ConditionsYield
In tetrahydrofuran at 100℃; for 24h; Sealed tube; High pressure;88%
2-amino-3-nitropyridine
4214-75-9

2-amino-3-nitropyridine

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

C5H5N3O2*C7H6O6S

C5H5N3O2*C7H6O6S

Conditions
ConditionsYield
In ethanol for 3h; Reflux;88%
1,2-bis(1H-benzo[d]imidazol-2-yl)ethane-1,2-diol
3314-32-7

1,2-bis(1H-benzo[d]imidazol-2-yl)ethane-1,2-diol

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

C16H14N4O2*2H2O*C7H6O6S

C16H14N4O2*2H2O*C7H6O6S

Conditions
ConditionsYield
With water In methanol; ethanol at 20℃;87.51%
H-Gly-NH2
598-41-4

H-Gly-NH2

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

glycinamide 5-sulfosalicylate
1336437-67-2

glycinamide 5-sulfosalicylate

Conditions
ConditionsYield
In methanol; water87%
2-amino-4-methyl-3-nitropyridine
6635-86-5

2-amino-4-methyl-3-nitropyridine

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

C6H7N3O2*C7H6O6S

C6H7N3O2*C7H6O6S

Conditions
ConditionsYield
In ethanol for 3h; Reflux;87%
3,5-dimethyl-1H-pyrazole
67-51-6

3,5-dimethyl-1H-pyrazole

cadmium(II) acetate dihydrate
5743-04-4

cadmium(II) acetate dihydrate

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

Cd(3,5-dimethylpyrazole)2(5-sulfosalicylate)2

Cd(3,5-dimethylpyrazole)2(5-sulfosalicylate)2

Conditions
ConditionsYield
In methanol at 20℃; for 2h;86.4%
pentaphenylantimony
2170-05-0

pentaphenylantimony

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

bis(tetraphenylstibonium) sulfosalicylate

bis(tetraphenylstibonium) sulfosalicylate

Conditions
ConditionsYield
In ethanol; toluene byproducts: C6H6; molar ratio Sb-compd./org. sulfonate 2/1; room temp., several min; evapn., recrystn. (ethanol-water, 5:1);86%
dichloro(phthalocyaninato)zirconium(IV)
59538-92-0

dichloro(phthalocyaninato)zirconium(IV)

5-sulfosalicylic Acid
97-05-2

5-sulfosalicylic Acid

phthalocyanine Zr(IV) 5-sulfosalicylic acid
380368-10-5

phthalocyanine Zr(IV) 5-sulfosalicylic acid

Conditions
ConditionsYield
In further solvent(s) byproducts: HCl; Zr-compd. suspended in 1-heptanol, 5-sulfosalicylic acid added, heated at 170°C for 8 h; filtered, hexane added, cooled, filtered, washed with excess of hexane, dried in air, dried in vac. at 60°C for 8 h;86%

Sulfosalicylic acid Chemical Properties

Empirical Formula: C7H6O6S
Molecular Weight: 218.1839 
EINECS: 202-555-6 
Index of Refraction: 1.649
Density: 1.771 g/cm3
Melting point: 120 °C
Appearance: White crystal or crystalline powder
Solubility: Soluble in water and Ethanol, soluble in Ether
Structure of 5-Sulphosalicylic acid (CAS NO.97-05-2):
                  

Sulfosalicylic acid Uses

 5-Sulphosalicylic acid (CAS NO.97-05-2) can be used as a pharmaceutical intermediate, and has been used in medicine doxycycline and A production of rare earth mycin.

Sulfosalicylic acid Production

 5-Sulphosalicylic acid (CAS NO.97-05-2) can be derived from salicylic acid obtained by sulfonation.

Sulfosalicylic acid Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
rabbit LDLo oral 1300mg/kg (1300mg/kg)   "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 565, 1969.
rabbit LDLo skin 7940mg/kg (7940mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: FOOD INTAKE (ANIMAL)
National Technical Information Service. Vol. OTS0570587,
rat LD50 oral 1850mg/kg (1850mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: FOOD INTAKE (ANIMAL)
GASTROINTESTINAL: OTHER CHANGES
National Technical Information Service. Vol. OTS0570587,

Sulfosalicylic acid Consensus Reports

Reported in EPA TSCA Inventory.

Sulfosalicylic acid Safety Profile

Moderately toxic by ingestion. Irritating to skin and mucous membranes. When heated to decomposition it emits toxic fumes of SOx. See also SULFONATES.

Sulfosalicylic acid Specification

 5-Sulphosalicylic acid ,its cas register number is 97-05-2. It also can be called 2-Hydroxy-5-sulfo-benzoic acid ; Benzoic acid, 2-hydroxy-5-sulfo- and Sulfosalicylic acid . 2 - hydroxy -5 - methyl-benzoic acid dihydrate is a white crystal or crystalline powder.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View